Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2014. Start Trial.
Date Value
November 13, 2026 2.199B
November 12, 2026 2.228B
November 11, 2026 2.224B
November 10, 2026 2.281B
November 09, 2026 2.332B
November 06, 2026 2.265B
November 05, 2026 2.310B
November 04, 2026 2.346B
November 03, 2026 2.287B
November 02, 2026 2.381B
October 30, 2026 2.283B
October 29, 2026 2.335B
October 28, 2026 2.405B
October 27, 2026 2.434B
October 26, 2026 2.369B
October 23, 2026 2.335B
October 22, 2026 2.300B
October 21, 2026 2.305B
October 20, 2026 2.285B
October 19, 2026 2.226B
October 16, 2026 2.221B
October 15, 2026 2.247B
October 14, 2026 2.187B
October 13, 2026 2.221B
October 12, 2026 2.263B
Date Value
October 09, 2026 2.222B
October 08, 2026 2.154B
October 07, 2026 2.066B
October 06, 2026 2.067B
October 05, 2026 2.064B
October 02, 2026 2.009B
October 01, 2026 2.003B
September 30, 2026 2.071B
September 29, 2026 2.164B
September 28, 2026 2.188B
September 25, 2026 2.175B
September 24, 2026 2.202B
September 23, 2026 2.216B
September 22, 2026 2.096B
September 21, 2026 2.096B
September 18, 2026 2.076B
September 17, 2026 2.065B
September 16, 2026 2.004B
September 15, 2026 2.039B
September 14, 2026 2.039B
September 11, 2026 2.053B
September 10, 2026 2.051B
September 09, 2026 2.049B
September 08, 2026 2.123B
September 04, 2026 2.245B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Evaxion AS 15.96M
Genmab A/S 34.93B
Ascendis Pharma A/S 17.48B
Zealand Pharma A/S 407.51M
Agenus, Inc. 487.93M